Drug Development

Celgene EVP Bagger gets a plum assignment on Trump team

BioCentury picked up a juicy bit of biotech-related presidential campaign news. Quoting sources, BioCentury says that Celgene EVP of corporate affairs Rich Bagger has taken a leave to work on Donald Trump’s transition team. That won’t get any flak from the top team at Celgene, as Executive Chairman Bob Hugin is a committed Republican and delegate pledged to back Trump at the Republican Convention this week.

But Trump may not have been Hugin’s first choice for the nomination.

According the federal election records, Hugin personally contributed $250,000 over the past year to America Leads, a super PAC that had backed New Jersey Governor Chris Christie’s run for the White House.

Bagger also has deep ties with the Republican Party, having served a 2-year stint as chief of staff to Christie. He has also been elected as a state senator in New Jersey, where Celgene is based.


The best place to read Endpoints News? In your inbox.

Comprehensive daily news report for those who discover, develop, and market drugs. Join 35,300+ biopharma pros who read Endpoints News by email every day.

Free Subscription

Biotech Investment Analyst
SV Health Investors Boston, MA
Research Scientist - Disease Biology
Recursion Pharmaceuticals Salt Lake City, UT
Senior Scientist - Predictive Pharmacology
Recursion Pharmaceuticals Salt Lake City, UT
Director, Translational Sciences
Cadent Therapeutics Cambridge, MA
Director of Marketing
twoXAR Mountain View, CA

Visit Endpoints Careers ->